Odyssey Therapeutics, Inc. Common Stock (ODTX) — Long-term Investment Intensity
Odyssey Therapeutics, Inc. Common Stock (ODTX) has a Long-term Investment Intensity of 25.3% as of June 2026. Long-term investments of $122.49 Million represent 25.3% of total assets of $483.85 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Odyssey Therapeutics, Inc. Common Stock (ODTX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Odyssey Therapeutics, Inc. Common Stock Long-term Investment Intensity (2023–2025)
This chart shows how Odyssey Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 2 annual periods from 2023 to 2025. As of June 2026, the intensity stands at 25.3%, reflecting long-term investments of $122.49 Million against total assets of $483.85 Million USD. See how many days can Odyssey Therapeutics, Inc. Common Stock fund operations to measure how many days the company can operate on defensive assets alone.
Annual Long-term Investment Intensity for Odyssey Therapeutics, Inc. Common Stock (2023–2025)
The table below presents the year-by-year Long-term Investment Intensity for Odyssey Therapeutics, Inc. Common Stock from 2023 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Odyssey Therapeutics, Inc. Common Stock.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 13.0% | $35.20 Million | $269.79 Million | ▲ +2.9 pp |
| 2023 | 10.2% | $29.10 Million | $286.52 Million | — |